Cognition reviewed topline efficacy and safety findings from the SHIMMER study of CT1812 in participants with dementia with Lewy bodies (DLB). This event featured a discussion with James E. Galvin, M.D., M.P.H., founding director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine and principal investigator in the SHIMMER study.
